Financial intelligence for Asia's healthcare markets
Remember me:

Singapore: Venturecraft sets up S$50million medtech fund

Private investment group Venturecraft has launched its second investment fund, Venturecraft Two, a S$50 million (US$36.8 million) fund aimed at medtech startups that are looking to expand in Asia.

It has been appointed a sector-specific accelerator by Spring Singapore for the medtech industry. This means that Spring Seeds Capital will co-invest in medtech companies with Venturecraft.

Each investment will be typically between S$500,000 and S$10million.

Venturecraft One, which was S$4million and launched last year, invested in a number of companies including AIM Biotech and Glissade Dental.

Posted on: 06/09/2016 UTC+08:00


Q&M Dental Group, which operates the largest network of private dental outlets in Singapore, is looking to delist its subsidiary Aidite from the National Equities Exchange and Quotations of the People’s Republic of China, also known as the New Third Board.
After a dispute going back 11 years, medical centre operator Primary Health Care (PRY) will now have to give its employees an up-to 20% pay increase after a Fair Work Commission awarded the workers at its Victoria pathology division workers higher allowances and back pay.
AUO Care, a subsidiary of electronics manufacturer AU Optronics, has formed a partnership with Suang-Lien Elderly Center in northern Taiwan to deliver real-time IoT-based smart healthcare solutions to elderly citizens.
Retirement village operator Summerset Group Holdings has priced its upsized seven year, fixed rate bonds at 4.2%. The margin for the bonds has been set at 1.65%.
Accuron MedTech, the largest medical device company in southeast Asia, has opened its new Technology Centre in Singapore.
Allergan, a global biopharmaceutical company and leader in medical aesthetics, and Alibaba Health, the flagship platform of Alibaba in the healthcare sector, announced that they have formed a strategic partnership to launch a medical aesthetics consumer education and consultation platform for the Chinese market.
Seoul-based ExoCoBio, which develops exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration, has raised about US$27 million in its series B funding. Top tier Korean investors participated in this round, including Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital, Atinum Investment, GU Equity Partners, QUANTUM Ventures Korea, and Platinum technology Investment.
Medical centre operator Primary Health Care (PRY) has completed the A$94 million (US$66.9 million) retail component of its fully underwritten 1-for-5.21 accelerated pro rata non-renounceable entitlement offer.


After listing on the Hong Kong Stock Exchange at the beginning of May, Ping An Healthcare and Technology, formerly known as Good Doctor, shows no sign of slowing down.
Amy Khor, senior minister of state, ministry of health in Singapore, looks at the challenges of how to deliver healthcare in the future.
First you must find a clinic space from which to practice. The good news is that space is available at most hospitals. The bad news is that a 1,200 square-foot clinic space at Mount Elizabeth Hospital currently retails for around S$10 million, or US$7.34 million to secure a space less than half the size of a tennis court. By the time you add fittings, equipment and staff, your relationship with your bank manager will likely be under severe strain.
China’s hospital landscape is rapidly changing as operators and owners respond to shifting policy incentives, an aging population, the opportunity to serve Tier 2 and 3 cities, and shifts in consumer preferences.
Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.
CR Phoenix Healthcare, China’s largest private hospital group, recently announced plans to restructure Beijing Jingmei Group General Hospital, a flagship hospital managed by CR Phoenix under its investment-operation-transfer (IOT) model.
Severe abuses continue in China's organ transplant system – including the sourcing of organs from prisoners of conscience on a large scale – despite Chinese government assertions of reform, finds a new study by the China Organ Harvest Research Center.
Asia Pacific's transition from a volume- to value-based care model has been highly challenging due to the need for large-scale regulatory changes and lack of a funding. Rising healthcare consumerism, digital health adoption, and the growing influence of medical tourism are setting a foundation for population health management, one form of value-based care that shifts the industry focus from episodic, individualised healthcare approaches to collective action against the cost and burden of disease in a society.
my images


HealthInvestor Asia twitter feed